Latest Shareholder Value News

MPower Group has finalized the sale of nearly all its assets to Wollemi Energy Group for about $19 million, setting the stage for a potential capital return or a new business acquisition.

Alkane Resources has unveiled its FY2026 production and cost guidance following its merger with Mandalay Resources, projecting significant growth across its Australian and Swedish operations.

CZR Resources has completed the sale of its Robe Mesa Iron Ore Project, netting over A$70 million and wiping out its debt. The company is now poised to accelerate exploration across its remaining Western Australian assets.

McLaren Minerals reports continued high-grade assay results confirming a significant northern extension to its McLaren Titanium Project resource, underpinning an upcoming resource upgrade and prefeasibility study.

AuKing Mining has locked in a A$5 million credit facility with RiverFort Global Capital to fast-track exploration and development at its Cloncurry Gold Project, setting the stage for near-term gold production in Queensland.

Dotz Nano Limited has raised approximately A$740,000 through unsecured loans featuring convertible options, aiming to bolster its working capital amid ongoing funding efforts.

Artrya Limited has raised A$75 million through a two-tranche placement and launched a A$5 million share purchase plan to fast-track the U.S. commercialisation of its AI-powered Salix platform following FDA clearance.

Lefroy Exploration is nearing operational readiness at its Lucky Strike Gold Deposit with key approvals and designs in place, while gearing up for a high-grade drilling campaign at Burns Central. The company is fully funded and poised for a self-funded growth phase.

NuEnergy Gas Limited has obtained government approval to sell 1 MMSCFD of coal bed methane gas in Indonesia, marking a pivotal step in its transition to production and supporting the country’s energy security goals.

High-Tech Metals Limited has appointed James Merrillees as CEO to spearhead exploration and production at its Mt Fisher and Mt Eureka gold projects, aiming to unlock significant value in Western Australia’s Northern Goldfields.

Wagners Holding Company Limited has secured $30 million through a strongly supported placement to fund growth in its construction materials and composite fibre technologies divisions.

Alterity Therapeutics has raised A$20 million through a strategic placement to advance its promising ATH434 treatment for Multiple System Atrophy, backed by encouraging Phase 2 trial results. The capital injection strengthens the company’s balance sheet as it prepares for regulatory discussions with the FDA.